Algernon Pharmaceuticals Appoints Novotech as CRO for First Phase 2 Trial and Announces Novotech’s $220K Equity Investment Biotech Investing
Lexaria Biosciences and Cannadips CBD reached definitive Technology Licensing agreement for CBD Oral Pouch & Dip Category Cannabis Investing News
BriaCell Outlines New High Responding Patient Group ‘Biomarker’ Based on Cancer Grade Biotech Investing
